·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ¼¿ïÀ¯ÅëÇù, °í¹® µî ÃÊû °£´ãȸ¡¥'ȸ¿ø»ç ´ÜÇÕ' °Á¶ ±â»çÀÔ·Â : 19.08.27 14:00:17 0 °¡ ÇÃÄ£Ãß°¡ AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] ¼¿ï½ÃÀǾàǰÀ¯ÅëÇùȸ(ȸÀå ¹ÚÈ£¿µ)ÀÌ Áö³ 26ÀÏ Èúµå·Î»çÀÌCC¿¡¼ °í¹® ¹× ÀÚ¹®À§¿ø, ȸÀå´Ü ÃÊû °£´ãȸ¸¦ °³ÃÖÇϰí Çö¾È ¹®Á¦ µîÀ» ³íÀÇÇß´Ù. À̳¯ °£´ãȸ¿¡¼ ÁøÁ¾È¯ °í¹®(Çѽžàǰ ȸÀå)Àº "Áö±Ý ¾î·Á¿î ½ÃÀýÀ» À̰ܳ»±â À§Çؼ´Â Çùȸ¸¦ Áß½ÉÀ¸·Î ¸ðµç ȸ¿ø»çµéÀÌ ÇÔ²² ÈûÀ» ¸ðÀ» ¶§"¶ó¸ç ȸ¿ø»çµé°£ ´ÜÇÕÀ» °Á¶Çß´Ù. ¹ÚÈ£¿µ ȸÀåÀº "ÀǾàǰÀ¯ÅëÇùȸ°¡ Áö±Ý±îÁö ¿Ã ¼ö ÀÖ¾ú´ø °ÍÀº ÀÌ ÀÚ¸®¿¡ °è½Å °í¹®, ÀÚ¹®À§¿øµéÀÇ ³ë·Â°ú Çå½ÅÀÌ ÀÖ¾ú±â ¶§¹®"À̶ó¸ç "ÀǾàǰ ¹Ýǰ, Á¦¾à»ç ¸¶Áø ÀÎÇÏ µî Çö¾È ¹®Á¦ µîÀÌ ¸¹ÀÌ ÀÖÁö¸¸ ȸ¿ø»çµé°£ ¼·Î ´ÜÇÕÇÑ´Ù¸é ¸ðµç ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖÀ» °Í"À̶ó°í ¸»Çß´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ ÀÌŹ¼ø ±âÀÚ(hooggasi2@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [¸ÓÅ©ÄÚ¸®¾Æ] Regulatory Affairs Specialist ¹Ù·Î°¡±â [°æ±âµµ ±¤ÁÖ] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¸ÂÃ㿵¾çÁ¦ ¸ÞµðÄÚÄ¡¿¡¼ ÇÁ¸®·£¼(¿Â¶óÀÎ »ó´ã À§ÁÖ) ¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù.(¼ö±Ý ¾ß°£/ÁÖ¸» »ó´ã) ¹Ù·Î°¡±â ¹é¾Ï°øÀå QA¾à»ç ä¿ë °æ·Â¹«°ü ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â Á¦¾à ¿µ¾÷ ½ÅÀÔ ¹× °æ·Â ä¿ë(¾Èµ¿) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿ïÀ¯ÅëÇù, °í¹® µî ÃÊû °£´ãȸ¡¥È¸¿ø»ç ´ÜÇÕ °Á¶ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¼¿ïÀ¯ÅëÇù, °í¹® µî ÃÊû °£´ãȸ¡¥'ȸ¿ø»ç ´ÜÇÕ' °Á¶ ±â»çÀÔ·Â : 19.08.27 14:00:17 0 °¡ ÇÃÄ£Ãß°¡ AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] ¼¿ï½ÃÀǾàǰÀ¯ÅëÇùȸ(ȸÀå ¹ÚÈ£¿µ)ÀÌ Áö³ 26ÀÏ Èúµå·Î»çÀÌCC¿¡¼ °í¹® ¹× ÀÚ¹®À§¿ø, ȸÀå´Ü ÃÊû °£´ãȸ¸¦ °³ÃÖÇϰí Çö¾È ¹®Á¦ µîÀ» ³íÀÇÇß´Ù. À̳¯ °£´ãȸ¿¡¼ ÁøÁ¾È¯ °í¹®(Çѽžàǰ ȸÀå)Àº "Áö±Ý ¾î·Á¿î ½ÃÀýÀ» À̰ܳ»±â À§Çؼ´Â Çùȸ¸¦ Áß½ÉÀ¸·Î ¸ðµç ȸ¿ø»çµéÀÌ ÇÔ²² ÈûÀ» ¸ðÀ» ¶§"¶ó¸ç ȸ¿ø»çµé°£ ´ÜÇÕÀ» °Á¶Çß´Ù. ¹ÚÈ£¿µ ȸÀåÀº "ÀǾàǰÀ¯ÅëÇùȸ°¡ Áö±Ý±îÁö ¿Ã ¼ö ÀÖ¾ú´ø °ÍÀº ÀÌ ÀÚ¸®¿¡ °è½Å °í¹®, ÀÚ¹®À§¿øµéÀÇ ³ë·Â°ú Çå½ÅÀÌ ÀÖ¾ú±â ¶§¹®"À̶ó¸ç "ÀǾàǰ ¹Ýǰ, Á¦¾à»ç ¸¶Áø ÀÎÇÏ µî Çö¾È ¹®Á¦ µîÀÌ ¸¹ÀÌ ÀÖÁö¸¸ ȸ¿ø»çµé°£ ¼·Î ´ÜÇÕÇÑ´Ù¸é ¸ðµç ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖÀ» °Í"À̶ó°í ¸»Çß´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ ÀÌŹ¼ø ±âÀÚ(hooggasi2@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [¸ÓÅ©ÄÚ¸®¾Æ] Regulatory Affairs Specialist ¹Ù·Î°¡±â [°æ±âµµ ±¤ÁÖ] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¸ÂÃ㿵¾çÁ¦ ¸ÞµðÄÚÄ¡¿¡¼ ÇÁ¸®·£¼(¿Â¶óÀÎ »ó´ã À§ÁÖ) ¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù.(¼ö±Ý ¾ß°£/ÁÖ¸» »ó´ã) ¹Ù·Î°¡±â ¹é¾Ï°øÀå QA¾à»ç ä¿ë °æ·Â¹«°ü ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â Á¦¾à ¿µ¾÷ ½ÅÀÔ ¹× °æ·Â ä¿ë(¾Èµ¿) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿ïÀ¯ÅëÇù, °í¹® µî ÃÊû °£´ãȸ¡¥È¸¿ø»ç ´ÜÇÕ °Á¶ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¼¿ïÀ¯ÅëÇù, °í¹® µî ÃÊû °£´ãȸ¡¥'ȸ¿ø»ç ´ÜÇÕ' °Á¶ ±â»çÀÔ·Â : 19.08.27 14:00:17 0 °¡ ÇÃÄ£Ãß°¡ AD 11¿ù 4ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] ¼¿ï½ÃÀǾàǰÀ¯ÅëÇùȸ(ȸÀå ¹ÚÈ£¿µ)ÀÌ Áö³ 26ÀÏ Èúµå·Î»çÀÌCC¿¡¼ °í¹® ¹× ÀÚ¹®À§¿ø, ȸÀå´Ü ÃÊû °£´ãȸ¸¦ °³ÃÖÇϰí Çö¾È ¹®Á¦ µîÀ» ³íÀÇÇß´Ù. À̳¯ °£´ãȸ¿¡¼ ÁøÁ¾È¯ °í¹®(Çѽžàǰ ȸÀå)Àº "Áö±Ý ¾î·Á¿î ½ÃÀýÀ» À̰ܳ»±â À§Çؼ´Â Çùȸ¸¦ Áß½ÉÀ¸·Î ¸ðµç ȸ¿ø»çµéÀÌ ÇÔ²² ÈûÀ» ¸ðÀ» ¶§"¶ó¸ç ȸ¿ø»çµé°£ ´ÜÇÕÀ» °Á¶Çß´Ù. ¹ÚÈ£¿µ ȸÀåÀº "ÀǾàǰÀ¯ÅëÇùȸ°¡ Áö±Ý±îÁö ¿Ã ¼ö ÀÖ¾ú´ø °ÍÀº ÀÌ ÀÚ¸®¿¡ °è½Å °í¹®, ÀÚ¹®À§¿øµéÀÇ ³ë·Â°ú Çå½ÅÀÌ ÀÖ¾ú±â ¶§¹®"À̶ó¸ç "ÀǾàǰ ¹Ýǰ, Á¦¾à»ç ¸¶Áø ÀÎÇÏ µî Çö¾È ¹®Á¦ µîÀÌ ¸¹ÀÌ ÀÖÁö¸¸ ȸ¿ø»çµé°£ ¼·Î ´ÜÇÕÇÑ´Ù¸é ¸ðµç ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖÀ» °Í"À̶ó°í ¸»Çß´Ù. X AD »çÀüµî·Ï GO À̺¥Æ®Âü¿© ¡æ ÀÌŹ¼ø ±âÀÚ(hooggasi2@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿ïÀ¯ÅëÇù, °í¹® µî ÃÊû °£´ãȸ¡¥È¸¿ø»ç ´ÜÇÕ °Á¶ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö